Lev Pharmaceuticals Inc (LEVP) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 75 transactions totaling $20.0M, demonstrating a bearish sentiment with -$5.2M in net insider flow. The most recent transaction on Oct 21, 2008 involved a transaction of 17,542,700 shares valued at $48.2M.
No significant insider buying has been recorded for LEVP in the recent period.
No significant insider selling has been recorded for LEVP in the recent period.
Based on recent SEC filings, insider sentiment for LEVP is bearish with an Insider Alignment Score of 37/100 and a net flow of -$5.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Lev Pharmaceuticals Inc (LEVP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading LEVP stock, having executed 75 transactions in the past 90 days. The most active insider is Christopher B. Madison (Executive), who has made 19 transactions totaling $51.5M.
Get notified when executives and directors at LEVP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 21, 2008 | Management Llc Mast Capital | Executive | Tender | 17,542,700 | $2.75 | $48.2M | Large |
| Oct 21, 2008 | Management Llc Mast Capital | Executive | Exercise | 900,000 | $1.66 | $1.5M | Large |
| Oct 21, 2008 | B. Madison Christopher | Executive | Tender | 17,642,700 | $2.75 | $48.5M | Large |
| Oct 21, 2008 | B. Madison Christopher | Executive | Exercise | 900,000 | $1.66 | $1.5M | Large |
| Oct 21, 2008 | J. Steinberg David | Executive | Tender | 17,582,700 | $2.75 | $48.4M | Large |
| Oct 21, 2008 | J. Steinberg David | Executive | Exercise | 900,000 | $1.66 | $1.5M | Large |
| Sep 30, 2008 | J. Steinberg David | Executive | Purchase | 556,200 | $2.10 | $1.2M | Large |
| Sep 30, 2008 | Management Llc Mast Capital | Executive | Purchase | 556,200 | $2.10 | $1.2M | Large |
| Sep 30, 2008 | B. Madison Christopher | Executive | Purchase | 556,200 | $2.10 | $1.2M | Large |
| Mar 29, 2008 | Opportunities I. Master Fund Ltd Mast Credit | Executive | Purchase | 2,500 | $0.85 | $2.1K | |
| Mar 29, 2008 | Opportunities I. Master Fund Ltd Mast Credit | Executive | Purchase | 112 | $0.90 | $101 | |
| Mar 29, 2008 | Opportunities I. Master Fund Ltd Mast Credit | Executive | Purchase | 2,688 | $0.87 | $2.3K | |
| Mar 29, 2008 | Opportunities I. Master Fund Ltd Mast Credit | Executive | Purchase | 6,700 | $0.86 | $5.8K | |
| Mar 29, 2008 | Opportunities I. Master Fund Ltd Mast Credit | Executive | Purchase | 2,500 | $0.85 | $2.1K | |
| Mar 29, 2008 | Opportunities I. Master Fund Ltd Mast Credit | Executive | Purchase | 56,000 | $0.88 | $49.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 3 | $145.1M | 85.5% |
Sale(S) | 2 | $12.6M | 7.4% |
Purchase(P) | 67 | $7.4M | 4.4% |
Exercise (Options)(X) | 3 | $4.5M | 2.6% |
Insider selling pressure at Lev Pharmaceuticals Inc has increased, with 8 insiders executing 75 transactions across all time. Total sales of $12.6M significantly outpace purchases of $7.4M, resulting in a net outflow of $5.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.